| Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
|---|
| 04/27/2005 | EP1423110A4 Cbi analogues of cc-1065 and the duocarmycins |
| 04/27/2005 | EP1419150B1 Phenylsulfonyl-1,3-dihydro-2h-indole-2-one derivatives, their preparation and their therapeutic use |
| 04/27/2005 | EP1261327B1 Adenosine receptor modulators |
| 04/27/2005 | EP0838453B1 Heterocyclic carboxylic acid derivatives and drugs containing the same |
| 04/27/2005 | CN1610679A Efficient process for the preparation of a factor XA inhibitor |
| 04/27/2005 | CN1610678A Pyrrolidone carboxamides |
| 04/27/2005 | CN1610667A 3-nitropyridine derivaives and the pharmaceutical compositions containing said derivatives |
| 04/27/2005 | CN1610666A Benzamidine derivative |
| 04/27/2005 | CN1610664A 3-azabicyclo (3.1.0) hexane derivatives as opioid receptor antagonists |
| 04/27/2005 | CN1610547A N-(2-arylethyl)benzylamines as antagonists of the 5-HT6 receptor |
| 04/27/2005 | CN1610546A 病毒聚合酶抑制剂 Viral polymerase inhibitor |
| 04/27/2005 | CN1198819C Benzimidazole derivatives |
| 04/27/2005 | CN1198806C Oxodiethylenediamine derivative and light stabilized composition |
| 04/27/2005 | CN1198803C Heterocyclic compounds having effect of activating nicoting acetylchloine alpha 4 beta 2 receptor |
| 04/27/2005 | CN1198801C Indole derivatives |
| 04/27/2005 | CN1198654C Pharmaceutical complex |
| 04/27/2005 | CN1198607C Composition for treating or preventing glomerulopathy |
| 04/26/2005 | US6885026 Organic element for electroluminescent devices |
| 04/26/2005 | US6884890 Anticancer, antitumor agents, antiarthritic agents |
| 04/26/2005 | US6884815 An amino compound containing imidazole and aromatic, or heteroaromatic rings is useful for treating inflammatory and immune system disorders |
| 04/26/2005 | US6884808 Acids and salts such as 4-(4-(2-(2-(5,6,7,8-Tetrahydro-5,5,8, 8-tetramethylquinoxalyl))pyrrolyl))benzoic acid, used retinoic acid receptor agonists for the prophylaxis of cancer, skin disorders, asthma, alopecia or autoimmune diseases |
| 04/26/2005 | US6884804 Inhibitors of Src and other protein kinases |
| 04/26/2005 | US6884801 Nitrogen compounds such as N-(4,5-dihydro-1H-imidazol-2-yl-methyl)-2-(methylsulfonyl)aniline, used for prophylaxis of incontinence |
| 04/26/2005 | US6884758 2,4-Diamino-1,3,5-triazines, their preparation, and their use as herbicides and plant growth regulators |
| 04/26/2005 | US6884266 Dyeing composition for dyeing keratinous fibers comprising a cationic azo-dye |
| 04/26/2005 | CA2239053C Diphenyl pyridyl ethane derivatives as pde iv inhibitors |
| 04/26/2005 | CA2053253C New aryl-and heteroarylethenylene derivatives and process for their preparation |
| 04/21/2005 | WO2005035528A2 Triazole derivatives as antibacterial agents |
| 04/21/2005 | WO2005035526A1 Bicyclic compounds and their therapeutic use |
| 04/21/2005 | WO2005035525A2 2-amido-4-aryloxy-1-carbonylpyrrolidine derivatives as inhibitors of serine proteases, particularly hcv ns3-ns4a protease |
| 04/21/2005 | WO2005035524A1 Pyrrolidinyl urea derivatives as angiogensis inhibitors |
| 04/21/2005 | WO2005035510A1 Derivatives of 4-phenylthiazoles and 4-phenylimidazoles and the use thereof as medicaments for treating neurodegenerative diseases, pain and epilepsy |
| 04/21/2005 | WO2005035508A2 Method for producing acyl urea derivatives, salts of said acyl urea derivatives, and the use thereof as pesticides |
| 04/21/2005 | WO2005035507A2 4-aminopyrimidine derivatives for treatment of hyperproliferative disorders |
| 04/21/2005 | WO2005035505A2 Compounds with phosphodiesterase inhibiting and calcium channel blocking activities |
| 04/21/2005 | WO2005035504A2 5-h -benzo [d] naphth [2, 1-b] azepine derivative as selective d1/d5 receptor antagonists for the treatment of obesity and cns disorders |
| 04/21/2005 | WO2005035498A1 Use of nitrogenous bicyclic compound as feeding control agent |
| 04/21/2005 | WO2005035493A1 Process for producing aminopyrrolidine derivative and intermediate compound |
| 04/21/2005 | WO2005034947A1 Aminobenzimidazoles as selective melanin concentrating hormone receptor antagonists for the treatment of obesity and related disorders |
| 04/21/2005 | WO2005034941A1 Indoles and azaindoles as antiviral agents |
| 04/21/2005 | WO2005034940A2 Dual alanyl aminopeptidase and dipeptidyl peptidase iv inhibitors for functionally influencing different cells and for treating immunological, inflammatory, neuronal and other diseases |
| 04/21/2005 | WO2005034870A2 Amide compounds and ion channel ligands and uses thereof |
| 04/21/2005 | WO2005011646A3 Nitrooxy derivatives of losartan, valsatan, candesartan, telmisartan, eprosartan and olmesartan as angiotensin-ii receptor blockers for the treatment of cardiovascular diseases |
| 04/21/2005 | WO2005005414A3 Pyrazolyl-indole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| 04/21/2005 | WO2005004801A3 Indole, azaindole and related heterocyclic n-substituted piperazine derivatives |
| 04/21/2005 | WO2004089286A3 Novel compounds and compositions as protein kinase inhibitors |
| 04/21/2005 | WO2004082616A3 Tetrahydropyranyl cyclopentyl heterocylic amide modulators of chemokine receptor activity |
| 04/21/2005 | WO2004031174A8 Imidazol-1-ylmethyl pyridazine derivatives |
| 04/21/2005 | US20050085667 N-biphenylmethyl aminocycloalkanecarboxamide derivatives |
| 04/21/2005 | US20050085639 Circulation disorders; antiproliferative agents; hypotensive agents; cardiovascular disorders; antiischemic agents; kidney disorders; atherosclerosis; restenosis; antiinflammatory agents; respiratory system disorders; angiogenesis inhibitors; anticancer agents; antiulcer agents |
| 04/21/2005 | US20050085541 Novel thyroid hormone receptor ligand, medicinal compositions containing the same and use thereof |
| 04/21/2005 | US20050085514 Psychological disorders; schizophrenia; anxiolytic agents; antidepressants; bipolar diseases; circadian rhythm disorders; analgesics; Parkinson's disease; Huntington's disease |
| 04/21/2005 | US20050085511 Cyclic diamines and derivatives as factor Xa inhibitors |
| 04/21/2005 | US20050085507 p-phenylethenyl hydroxamates; anticarcinogenic, antitumor, antiproliferative agents; regulating p21 promoter; improved stability |
| 04/21/2005 | US20050085502 Phenyl-substituted imidazopyridines |
| 04/21/2005 | US20050085501 Phenyl-substituted imidazopyridines |
| 04/21/2005 | US20050085497 Anticholesterol agents; reducing blood serum lipids; anticancer agents; antiarthritic agents; antiinflammatory agents; antitumor agents; immunosuppressants; obesity; hypotensive agents |
| 04/21/2005 | US20050085493 Quinazolinone derivatives and their use as cb agonists |
| 04/21/2005 | US20050085488 nitrogen compounds used as preferential inhibitors of cyclic peptide, for prophylaxis of metabolic disorders |
| 04/21/2005 | US20050085487 Heterocyclic compounds |
| 04/21/2005 | US20050085476 Polymerase inhibitors; antiischemic agents; brain disorders; cardiovascular disorders; antiinflammatory agents; antiarthritic agents; neurodegenerative agents; Alzheimer's disease; muscular disorders; antidiabetic agents; kidney disorders; viricides; anticancer agents; immunosuppressants |
| 04/21/2005 | US20050085465 Quinazoline compounds |
| 04/21/2005 | US20050084463 Antiinflammatory, antiarthritic agents, analgesics for pain caused by diabetic assoicated conditions, pneumoconiosis, angina, menstruation or cancer |
| 04/21/2005 | CA2542031A1 Pyrimidine derivatives for treatment of hyperproliferative disorders |
| 04/21/2005 | CA2542012A1 A method for producing aminopyrrolidine derivatives and intermediate compounds |
| 04/21/2005 | CA2541667A1 Substituted pyrazinone compounds for the treatment of inflammation |
| 04/21/2005 | CA2541582A1 Indoles and azaindoles as antiviral agents |
| 04/21/2005 | CA2540868A1 Pyrrolidinyl urea derivatives as angiogenesis inhibitors |
| 04/21/2005 | CA2526017A1 5-h-benzo[d]naphth[2,1-b]azepine derivative as selective d1/d5 receptor antagonists for the treatment of obesity and cns disorders |
| 04/20/2005 | EP1523481A1 3-guanidinocarbonyl-1-heteroaryl-indole derivatives, preparation process, their use as medicaments, and pharmaceutical compositions comprising them |
| 04/20/2005 | EP1523480A2 Derivatives of 3-guanidinocarbonyl-1-heteroaryl-pyrrole, process for their preparation and their pharmaceutical use |
| 04/20/2005 | EP1523473A1 Indoline derivatives substituted in position 6, production and use thereof as medicaments |
| 04/20/2005 | EP1443934B1 Benzotriazepines as gastrin and cholecystokinin receptor ligands |
| 04/20/2005 | EP1392316B1 Benzo[d]azepine derivatives as 5-ht6 receptor antagonists. |
| 04/20/2005 | EP1254133B1 Indol-3-yl derivatives and their use as integrin inhibitors |
| 04/20/2005 | EP1200414B1 Process for the preparation of substituted pyrimidines |
| 04/20/2005 | EP1042287B1 Indole derivatives as inhibitors of factor xa |
| 04/20/2005 | EP1029851B1 Piperazine compounds and medicinal use thereof |
| 04/20/2005 | CN1608086A Water-dispersible, cationic polymers, a method of making same and items using same |
| 04/20/2005 | CN1608065A Phenyl substituted triazoles and their use as selective inhibors of akl5 kinase and pharmaceutical compositions containing the compounds |
| 04/20/2005 | CN1608063A Indolinone derivatives |
| 04/20/2005 | CN1607951A Quinoline derivatives as neuropeptide y antagonists |
| 04/20/2005 | CN1197862C 2-(3, 5-disubstituted-4-pyridyl)-4-arylphenyl-1, 3-oxazoline compounds |
| 04/20/2005 | CN1197860C FAB I inhibitors |
| 04/20/2005 | CN1197849C 2, 3, 4, 5-tetrahydro-1H-[1, 4] benzodiazepine-3-hydroxamic acid as matrix metalloproteinase inhibitors |
| 04/20/2005 | CN1197458C Herbicidal synergic composition and method for controlling weed |
| 04/19/2005 | US6881844 Indole-3-carboxamides as glucokinase activators |
| 04/19/2005 | US6881740 Pharmaceutical agents |
| 04/19/2005 | US6881737 Substituted triazinyl acrylamide derivatives and methods of use |
| 04/19/2005 | US6881727 Sulfonated amino acid derivatives and metalloproteinase inhibitors containing the same |
| 04/19/2005 | CA2295035C Pharmaceutical formulations containing voriconazole |
| 04/14/2005 | WO2005033930A2 Process for upgrading naphtha |
| 04/14/2005 | WO2005033108A1 7-amino alkylidenyl-heterocyclic quinolones and naphthyridones |
| 04/14/2005 | WO2005033105A2 Vanilloid receptor ligands and their use in treatments |
| 04/14/2005 | WO2005033104A1 Use of a compound of formula (i) as an inhibitor of aromatase for therapeutic purposes and compounds of formula (1) thereas |
| 04/14/2005 | WO2005033099A2 Novel dipeptidyl peptidase iv inhibitors; processes for their preparation and compositions thereof |
| 04/14/2005 | WO2005033098A1 Salts and polymorphs of a pyrrole-substituted indolinone compound |
| 04/14/2005 | WO2005033088A1 Quinoxaline compounds |
| 04/14/2005 | WO2005033086A1 Compounds and compositions as protein kinase inhibitors |
| 04/14/2005 | WO2005033077A1 Sequence selective pyrrole and imidazole polyamide metallocomplexes |